• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.20% Nasdaq Up0.41%

    IGI Laboratories, Inc. (IG)

    7.57 0.00(0.00%) Oct 9, 4:00PM EDT
    ProfileGet Profile for:
    IGI Laboratories, Inc.
    105 Lincoln Avenue
    Buena, NJ 08310
    United States - Map
    Phone: 856-697-1441
    Website: http://www.igilabs.com

    Index Membership:N/A
    Full Time Employees:81

    Business Summary 

    IGI Laboratories, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets topical formulations in the United States. It sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms under IGI label. The company also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter (OTC) and cosmetic markets. Its products are used in various applications from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, the company offers pharmaceutical contract services comprising formulating, testing, and/or manufacturing prescription drugs and medical devices; and contract development services consisting of developing topical formulations. It has a license agreement with Novavax, Inc. to utilize the Novasome lipid vesicle encapsulation and certain other technologies for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological OTC and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals. The company was formerly known as IGI, Inc. and changed its name to IGI Laboratories, Inc. in May 2008. IGI Laboratories, Inc. was founded in 1977 and is based in Buena, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IGI Laboratories, Inc.

    Corporate Governance 
    IGI Laboratories, Inc.’s ISS Governance QuickScore as of Oct 1, 2015 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 3; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Jason Grenfell-Gardner , 40
    Chief Exec. Officer, Pres and Director
    Mrs. Jenniffer L. Collins , 45
    Chief Financial Officer and Sec.
    Mr. Sanjay Samudre ,
    Director of Operations
    Mr. Stephen Richardson ,
    Chief Scientific Officer
    Mr. Thomas Vandervort ,
    VP of Bus. Devel.
    Ms. Nadya Lawrence , 46
    Sr. Vice-Pres of Contract Services
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders